Dark

Check out our Dark Pool Levels

BEAM
Beam Therapeutics Inc. Common Stock
stock NASDAQ

At Close

Jul 31, 2026 3:59:56 PM EDT

25.50USD-3.737%(-0.99)1,067,747

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 31, 2026 9:26:30 AM EDT

26.76USD+1.019%(+0.27)2,223

After-hours

Jul 31, 2026 4:00:30 PM EDT

25.52USD+0.078%(+0.02)198,416

OverviewOptionsHistoricalExchangesShortsTrends

BEAM Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

BEAM Specific Mentions

As of Aug 1, 2026 9:55:40 AM EDT (1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

10 days ago • u/WhaleAxolotl • r/biotech_stocks • intellia_theraputics • C

Do you have any sources that describe why BEAM has the most powerful gene editing technology?

10 days ago • u/GaiusMarius7Times • r/pennystocks • beam_global_beem_is_priced_like_a_penny_stock_but • :snoo_dealwithit: General Discussion :snoo_dealwithit: • T

BEAM global $BEEM is priced like a penny stock, but isnt.

10 days ago • u/atqifja • r/biotech_stocks • intellia_theraputics • C

BEAM is still early stage,no one know how safe it is yet, NTLA has concrete evidence and flawless safety profile
I think this is beeing shorted by institutions, which is keeping the price back
If/when they back out, and NTLaa-2002 has commercial succes i could see this 10x

10 days ago • u/Origid_3295 • r/biotech_stocks • intellia_theraputics • C

I agree its very cheap right now. Heres what i think why it might be. ATTR program was temporarily paused after a patient death during treatment. This was what caused a crash a couple months back. It's been lifted now.
HAE is a competitive market, and from my understanding Garadacimab has similar results to NTLA-2002. Of course that's very impressive for a one time cure, but I'm not 100% sure it becomes SOC.
Also new technology coming out from BEAM is arguably going to be more powerful/precise in gene editing, both CRSP and NTLA are no longer the most cutting edge clinical gene editing companies.

sentiment -0.83

10 days ago • u/WhaleAxolotl • r/biotech_stocks • intellia_theraputics • C

Do you have any sources that describe why BEAM has the most powerful gene editing technology?

10 days ago • u/GaiusMarius7Times • r/pennystocks • beam_global_beem_is_priced_like_a_penny_stock_but • :snoo_dealwithit: General Discussion :snoo_dealwithit: • T

BEAM global $BEEM is priced like a penny stock, but isnt.

10 days ago • u/atqifja • r/biotech_stocks • intellia_theraputics • C

BEAM is still early stage,no one know how safe it is yet, NTLA has concrete evidence and flawless safety profile
I think this is beeing shorted by institutions, which is keeping the price back
If/when they back out, and NTLaa-2002 has commercial succes i could see this 10x

10 days ago • u/Origid_3295 • r/biotech_stocks • intellia_theraputics • C

I agree its very cheap right now. Heres what i think why it might be. ATTR program was temporarily paused after a patient death during treatment. This was what caused a crash a couple months back. It's been lifted now.
HAE is a competitive market, and from my understanding Garadacimab has similar results to NTLA-2002. Of course that's very impressive for a one time cure, but I'm not 100% sure it becomes SOC.
Also new technology coming out from BEAM is arguably going to be more powerful/precise in gene editing, both CRSP and NTLA are no longer the most cutting edge clinical gene editing companies.

sentiment -0.83

Share